The Impact of Mobile APP Intervention ( iCKD APP) on Chronic Kidney Disease Care
The Impact of Mobile APP Intervention ( iCKD APP) on Chronic Kidney Disease Care
-  Apply Mobile APP Intervention ( iCKD APP) to current chronic kidney disease care
 program.

 -  Conduct a randomized clinical trial to evaluate the clinical effectiveness of this
 mobile device on health behavior improvement in chronic kidney disease patients.
A mHealth app (iCKD APP) was designed to assist CKD patients to monitor their home
 bio-information data. Patients will be randomly assigned into the iCKD APP
 group(intervention) and traditional care group (control). Participants will be randomized
 into an 1:1 manner (intervention : control). Random assignment occurred after the consent and
 initial enrollment interview. Individuals randomized to the iCKD APP will provide with the
 equipment after randomization. Participants will follow for at least 6 months before the exit
 interview.
Inclusion Criteria:

 -  Subjects are 20 years old and above, Chinese speaking, and able and willing to provide
 informed consent.

 -  Subjects own mobile devices such as cell phones and tablets.

 -  Subjects were diagnosed with Chronic Kidney Diseases and were taking a single
 antihypertensive agent for more than three months or they are not receiving treatment
 but with systolic blood pressure ≥140 mmHg or diastolic blood pressure ≥90 mmHg.

 Exclusion Criteria:

 -  starting dialysis or having a kidney transplant (RRT)

 -  participating in other interventional study

 -  cognitively impaired

 -  unable to give consent

 -  life expectancy less than 1 year